1. Home
  2. VIR vs TDOC Comparison

VIR vs TDOC Comparison

Compare VIR & TDOC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VIR
  • TDOC
  • Stock Information
  • Founded
  • VIR 2016
  • TDOC 2002
  • Country
  • VIR United States
  • TDOC United States
  • Employees
  • VIR N/A
  • TDOC N/A
  • Industry
  • VIR Biotechnology: Pharmaceutical Preparations
  • TDOC Medical/Nursing Services
  • Sector
  • VIR Health Care
  • TDOC Health Care
  • Exchange
  • VIR Nasdaq
  • TDOC Nasdaq
  • Market Cap
  • VIR 1.4B
  • TDOC 1.6B
  • IPO Year
  • VIR 2019
  • TDOC 2015
  • Fundamental
  • Price
  • VIR $7.00
  • TDOC $8.50
  • Analyst Decision
  • VIR Buy
  • TDOC Buy
  • Analyst Count
  • VIR 6
  • TDOC 18
  • Target Price
  • VIR $35.67
  • TDOC $11.26
  • AVG Volume (30 Days)
  • VIR 1.1M
  • TDOC 11.7M
  • Earning Date
  • VIR 05-01-2025
  • TDOC 04-24-2025
  • Dividend Yield
  • VIR N/A
  • TDOC N/A
  • EPS Growth
  • VIR N/A
  • TDOC N/A
  • EPS
  • VIR N/A
  • TDOC N/A
  • Revenue
  • VIR $74,205,000.00
  • TDOC $2,569,574,000.00
  • Revenue This Year
  • VIR N/A
  • TDOC N/A
  • Revenue Next Year
  • VIR $17.69
  • TDOC $1.48
  • P/E Ratio
  • VIR N/A
  • TDOC N/A
  • Revenue Growth
  • VIR N/A
  • TDOC N/A
  • 52 Week Low
  • VIR $6.56
  • TDOC $6.76
  • 52 Week High
  • VIR $14.45
  • TDOC $15.68
  • Technical
  • Relative Strength Index (RSI)
  • VIR 28.28
  • TDOC 33.57
  • Support Level
  • VIR $6.96
  • TDOC $8.62
  • Resistance Level
  • VIR $7.46
  • TDOC $9.24
  • Average True Range (ATR)
  • VIR 0.57
  • TDOC 0.65
  • MACD
  • VIR -0.16
  • TDOC -0.25
  • Stochastic Oscillator
  • VIR 1.56
  • TDOC 0.44

About VIR Vir Biotechnology Inc.

Vir Biotechnology Inc is an immunology company focused on combining cutting-edge technologies to treat and prevent serious infectious diseases and other serious conditions, including viral-associated diseases. Through internal development, collaborations, and acquisitions, it has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA. The company's pipeline consists of product candidates targeting hepatitis B, HBV, influenza A, human immunodeficiency virus, HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue, and license revenue.

About TDOC Teladoc Health Inc.

Teladoc Health is a virtual health provider with a telehealth platform delivering on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. It operates in Teladoc two segments Health Integrated Care and BetterHelp segments. The majority of its revenue generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has partnered with employers, health plans, and health systems to offer network access to their members; it has also started to market directly to consumers while expanding its service portfolio.

Share on Social Networks: